Virax Biolabs

Home
United Kingdom
London
Virax Biolabs

Biotechnology company focused on detection of immune responses to & diagnosis of viral diseases

Virax Biolabs is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases.

17/03/2025

CLP Magagazine's latest article dives into the data presented by Virax Biolabs at the 19th World Immune Regulation Meeting in Davos, Switzerland. The study highlights how T cell exhaustion markers impact post-acute infection syndromes (PAIS) like long COVID, ME/CFS, and chronic Lyme disease.

Don’t miss it - read the full article now at: https://clpmag.com/diagnostic-technologies/immunoassay/t-cell-dysfunction-in-post-acute-infection-syndromes-presented/

13/03/2025

Virax Biolabs shared new insights on T cell exhaustion in post-acute infection syndromes (PAIS) like long COVID, ME/CFS, and chronic Lyme disease at the 19th World Immune Regulation Meeting this week.

To view our findings and read our press release: https://ir.viraxbiolabs.com/news-events/press-releases/detail/70/virax-biolabs-presents-data-on-t-cell-dysfunction-in?mc_cid=21b90e2800&mc_eid=9190988cab

Stay tuned for more on our ongoing clinical studies!

12/03/2025

Our team is at the World Immune Regulation Meeting 2025!

You can find us at Booth 116 until the end of the conference - we're always happy to connect & talk about our ViraxImmune range of T cell assays and immune profiling products.

Come say hi!

05/03/2025

We’re thrilled to announce that our team will be presenting at the 19th World Immune Regulation Meeting (WIRM) in Davos, Switzerland, from March 12-15th.

Dr. Nigel McCracken, our Chief Operating Officer, will present on "Evaluation of T cell dysfunction in Post-Acute Infection Syndromes" on March 12th at 8pm in Foyer A1.

Plus, stop by our Booth 116 to learn about our cutting-edge immune profiling products!

You can read our press release here: https://lnkd.in/e3sNdjQH

03/03/2025

Exciting Event Alert!

Join us for Inside Precision Medicine's FREE State of Precision Medicine Summit on Wednesday, March 5th, 2025.

One of the key highlights is the "State of Molecular Diagnostics" panel at 2:30pm EST, featuring industry leaders including Virax Biolab’s COO, Dr Nigel McCracken, and moderated by North American Editor Jonathan Grinstein.

Gain valuable insights into the latest advancements in molecular diagnostics - don't miss out!

Register now: https://webinars.liebertpub.com/e/u/checkout/The-State-of-Precision-Medicine-2025/tickets/order

25/02/2025

Virax Biolabs is leading the charge in vaccine transparency!

Our cutting-edge tech delivers data-driven insights on vaccine efficacy & long-term immunity, empowering informed health choices.

Read our press release: https://ir.viraxbiolabs.com/news-events/press-releases/detail/68/virax-biolabs-believes-technology-aligns-with-united-states

21/02/2025

Big things are ahead for biotech in 2025!

In a new article by Citeline, industry leaders including Virax Biolabs CEO, James Foster, share their predictions on key biotech developments to watch for this year. James talks about the rising demand for in vitro diagnostics (IVDs) for post-acute infection syndromes and how innovations in this space will help streamline diagnosis, reduce costs, and improve patient outcomes.

Read the full article here: https://insights.citeline.com/scrip/scrip-asks/scrip-asks-what-does-2025-hold-for-biopharma-part-6-therapeutic-area-advances-6YGXHKRX4NE4DOBZ4AM7IFN2YY/

19/02/2025

CEO James Foster shares insights on navigating global launch strategies amid political uncertainty. From adapting to shifting regulatory landscapes to staying nimble in challenging times, we’re staying ahead of the game.

Check out the interview with Pharmaceutical Executive Magazine here: https://www.pharmexec.com/view/global-launch-strategies-current-political-climate

04/02/2025

Lyme Disease is the most common tick-related infection, but is still far too difficult to diagnose. Virax Biolabs is aiming to change that.

To find out more about our work on Lyme Disease, you can read the CLP article here: https://clpmag.com/disease-states/allergy-autoimmune/lyme-disease-are-we-close-to-an-effective-diagnostic-test/

24/01/2025

We're thrilled to be featured in 's latest article, "Combating Chronic Inflammation through Immune Diagnostics"!

Click here to read more about out how we're pioneering solutions to tackle chronic inflammation: https://longevity.technology/news/combating-chronic-inflammation-through-immune-diagnostics/

17/12/2024

Today, our CEO, James Foster, issues his letter to our shareholders. He details our work this year to commercialize our ImmuneSelect Research-Use Only range, outlines the expected regulatory progress for our ViraxImmune IVD platform in 2025, and more.

Read the letter in full here: https://ir.viraxbiolabs.com/news-events/press-releases/detail/67/virax-biolabs-ceo-james-foster-issues-letter-to

10/12/2024

We're excited to announce that we have entered into an agreement with Tebubio to expand distribution of our ImmuneSelect Research-Use Only range into the European Union, Norway, and Switzerland! This collaboration will allow us to facilitate immune health research in even more parts of the European market.

Read our press release here: https://ir.viraxbiolabs.com/news-events/press-releases/detail/66/virax-biolabs-announces-agreement-with-tebubio-to-expand

Address

London

Telephone

+442077887414

Website

https://www.viraxbiolabs.com/

Alerts

Be the first to know and let us send you an email when Virax Biolabs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

Help Mind Body

Want your practice to be the top-listed Clinic in London?